Literature DB >> 24126140

Incident fractures in HIV-infected individuals: a systematic review and meta-analysis.

Stephanie Shiau1, Emily C Broun, Stephen M Arpadi, Michael T Yin.   

Abstract

OBJECTIVE(S): Some but not all studies indicate that individuals with HIV infection are at an increased risk of fracture. We systematically reviewed the literature to investigate whether incidence of fracture (both overall and fragility) differs between individuals with and without HIV.
DESIGN: A systematic review and meta-analysis.
METHODS: Medline, Scopus and the Cochrane Library databases for all studies ever published up to 28 September 2012 and electronically available conference abstracts from CROI, ASBMR, IAS and AIDS were searched. All studies reporting incidence of all fracture and fragility fracture in HIV-infected adults were included. A random effects model was used to calculate pooled estimates of incidence rate ratios (IRRs) for studies that presented data for HIV-infected and controls. For all studies, incidence rates of fracture and predictors of fracture among HIV-infected individuals were summarized.
RESULTS: Thirteen eligible studies were analysed, of which seven included controls. Nine studies reported all incident fractures and 10 presented incident fragility fractures. The pooled IRR was 1.58 [95% confidence interval (CI) 1.25-2.00] for all fracture and 1.35 (95% CI 1.10-1.65) for fragility fracture. Smoking, white race and older age were consistent predictors for fragility fractures.
CONCLUSION: Our results indicate that HIV infection is associated with a modest increase in incident fracture. Future research should focus on clarifying risk factors, designing appropriate interventions and the long-term implications of this increased risk for an ageing HIV-infected population.

Entities:  

Mesh:

Year:  2013        PMID: 24126140      PMCID: PMC4030545          DOI: 10.1097/QAD.0b013e328361d241

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  30 in total

1.  Risk of hip fracture associated with hepatitis C virus infection and hepatitis C/human immunodeficiency virus coinfection.

Authors:  Vincent Lo Re; Jessica Volk; Craig W Newcomb; Yu-Xiao Yang; Cristin P Freeman; Sean Hennessy; Jay R Kostman; Pablo Tebas; Mary B Leonard; A Russell Localio
Journal:  Hepatology       Date:  2012-10-14       Impact factor: 17.425

2.  Hip bone geometry in HIV/HCV-co-infected men and healthy controls.

Authors:  V Walker Harris; C G Sutcliffe; A B Araujo; G R Chiu; T G Travison; S Mehta; M S Sulkowski; Y Higgins; D L Thomas; A S Dobs; T J Beck; T T Brown
Journal:  Osteoporos Int       Date:  2011-09-08       Impact factor: 4.507

3.  HIV protease inhibitors selectively induce gene expression alterations associated with reduced calcium deposition in primary human osteoblasts.

Authors:  Andrea P Malizia; Eoin Cotter; Nicholas Chew; William G Powderly; Peter P Doran
Journal:  AIDS Res Hum Retroviruses       Date:  2007-02       Impact factor: 2.205

4.  Decreased bone mineral density and increased fracture risk in aging men with or at risk for HIV infection.

Authors:  Julia H Arnsten; Ruth Freeman; Andrea A Howard; Michelle Floris-Moore; Yungtai Lo; Robert S Klein
Journal:  AIDS       Date:  2007-03-12       Impact factor: 4.177

Review 5.  Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review.

Authors:  Todd T Brown; Roula B Qaqish
Journal:  AIDS       Date:  2006-11-14       Impact factor: 4.177

6.  The HIV protease inhibitor ritonavir blocks osteoclastogenesis and function by impairing RANKL-induced signaling.

Authors:  Michael W-H Wang; Shi Wei; Roberta Faccio; Sunao Takeshita; Pablo Tebas; William G Powderly; Steven L Teitelbaum; F Patrick Ross
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

7.  HIV-1 Vpr enhances production of receptor of activated NF-kappaB ligand (RANKL) via potentiation of glucocorticoid receptor activity.

Authors:  J M Fakruddin; J Laurence
Journal:  Arch Virol       Date:  2004-09-24       Impact factor: 2.574

8.  Fractures after antiretroviral initiation.

Authors:  Michael T Yin; Michelle A Kendall; Xingye Wu; Katherine Tassiopoulos; Marc Hochberg; Jeannie S Huang; Marshall J Glesby; Hector Bolivar; Grace A McComsey
Journal:  AIDS       Date:  2012-11-13       Impact factor: 4.177

9.  Low bone mass in behaviorally HIV-infected young men on antiretroviral therapy: Adolescent Trials Network Study 021B.

Authors:  Kathleen Mulligan; D Robert Harris; Patricia Emmanuel; Roger A Fielding; Carol Worrell; Bill G Kapogiannis; Dina Monte; John Sleasman; Craig M Wilson; Grace M Aldrovandi
Journal:  Clin Infect Dis       Date:  2012-05-09       Impact factor: 9.079

10.  CD4+ count-guided interruption of antiretroviral treatment.

Authors:  W M El-Sadr; J D Lundgren; J D Neaton; F Gordin; D Abrams; R C Arduino; A Babiker; W Burman; N Clumeck; C J Cohen; D Cohn; D Cooper; J Darbyshire; S Emery; G Fätkenheuer; B Gazzard; B Grund; J Hoy; K Klingman; M Losso; N Markowitz; J Neuhaus; A Phillips; C Rappoport
Journal:  N Engl J Med       Date:  2006-11-30       Impact factor: 91.245

View more
  67 in total

Review 1.  Geriatric syndromes: new frontiers in HIV and sarcopenia.

Authors:  Kellie L Hawkins; Todd T Brown; Joseph B Margolick; Kristine M Erlandson
Journal:  AIDS       Date:  2017-06-01       Impact factor: 4.177

2.  Fractures Are Not Associated with CD8(+) T Cell Activation: An Analysis of the ACTG ALLRT Study.

Authors:  Michelle A Kendall; Katherine Tassiopoulos; Grace A McComsey; Michael T Yin
Journal:  AIDS Res Hum Retroviruses       Date:  2015-07-16       Impact factor: 2.205

Review 3.  Bone Density and Fractures in HIV-infected Postmenopausal Women: A Systematic Review.

Authors:  Yamnia I Cortés; Michael T Yin; Nancy K Reame
Journal:  J Assoc Nurses AIDS Care       Date:  2015-04-03       Impact factor: 1.354

Review 4.  Management of endocrine disease: Secondary osteoporosis: pathophysiology and management.

Authors:  Faryal Mirza; Ernesto Canalis
Journal:  Eur J Endocrinol       Date:  2015-05-13       Impact factor: 6.664

5.  Tenofovir Has Minimal Effect on Biomarkers of Bone Health in Youth with HIV Receiving Initial Antiretroviral Therapy.

Authors:  Julie J Kim-Chang; Lorena Wilson; Cliburn Chan; Bernard Fischer; Guglielmo Venturi; Maureen M Goodenow; Grace Aldrovandi; Thomas J Weber; John W Sleasman
Journal:  AIDS Res Hum Retroviruses       Date:  2019-06-27       Impact factor: 2.205

6.  The Current State of HIV and Aging: Findings Presented at the 10th International Workshop on HIV and Aging.

Authors:  Stephanie Shiau; Alexis A Bender; Jane A O'Halloran; Erin Sundermann; Juhi Aggarwal; Keri N Althoff; Jason V Baker; Steven Deeks; Linda P Fried; Stephen Karpiak; Maile Y Karris; Thomas D Marcotte; Jean B Nachega; Joseph B Margolick; Kristine M Erlandson; David J Moore
Journal:  AIDS Res Hum Retroviruses       Date:  2020-09-23       Impact factor: 2.205

7.  Reduced Serum Osteocalcin in High-Risk Alcohol Using People Living With HIV Does Not Correlate With Systemic Oxidative Stress or Inflammation: Data From the New Orleans Alcohol Use in HIV Study.

Authors:  James Watt; Jonathan Schuon; Jacob Davis; Tekeda F Ferguson; David A Welsh; Patricia E Molina; Martin J J Ronis
Journal:  Alcohol Clin Exp Res       Date:  2019-10-01       Impact factor: 3.455

8.  Bone Quality Measured Using Calcaneal Quantitative Ultrasonography Is Reduced Among Children with HIV in Johannesburg, South Africa.

Authors:  Stephen M Arpadi; Cara B Thurman; Faeezah Patel; Jonathan J Kaufman; Renate Strehlau; Megan Burke; Stephanie Shiau; Ashraf Coovadia; Michael T Yin
Journal:  J Pediatr       Date:  2019-08-29       Impact factor: 4.406

Review 9.  Alcohol Use and Human Immunodeficiency Virus (HIV) Infection: Current Knowledge, Implications, and Future Directions.

Authors:  Emily C Williams; Judith A Hahn; Richard Saitz; Kendall Bryant; Marlene C Lira; Jeffrey H Samet
Journal:  Alcohol Clin Exp Res       Date:  2016-09-22       Impact factor: 3.455

10.  Clinically Indicated Corticosteroids Do Not Affect Bone Turnover During Immune Restoration of Severely Lymphopenic HIV-Infected Patients.

Authors:  Philip M Grant; Virginia Sheikh; Rebecca DerSimonian; Adam Rupert; Gregg Roby; Alice Pau; Michael C Sneller; Sheryl-Vi Rico; Todd T Brown; Irini Sereti
Journal:  AIDS Res Hum Retroviruses       Date:  2015-05-21       Impact factor: 2.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.